249 related articles for article (PubMed ID: 15182226)
1. Experimental approaches to TSE prevention via inhibition of prion formation.
Politopoulou G
Protein Pept Lett; 2004 Jun; 11(3):249-55. PubMed ID: 15182226
[TBL] [Abstract][Full Text] [Related]
2. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
[TBL] [Abstract][Full Text] [Related]
3. Prion protein interconversions.
Caughey B
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):197-200; discussion 200-2. PubMed ID: 11260800
[TBL] [Abstract][Full Text] [Related]
4. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
5. Host and transmissible spongiform encephalopathy agent strain control glycosylation of PrP.
Somerville RA
J Gen Virol; 1999 Jul; 80 ( Pt 7)():1865-1872. PubMed ID: 10423157
[TBL] [Abstract][Full Text] [Related]
6. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?
Caughey B; Caughey WS; Kocisko DA; Lee KS; Silveira JR; Morrey JD
Acc Chem Res; 2006 Sep; 39(9):646-53. PubMed ID: 16981681
[TBL] [Abstract][Full Text] [Related]
7. Prion: toxic or infectious agent?
Rico A
Med Hypotheses; 2003 Feb; 60(2):209-14. PubMed ID: 12606237
[TBL] [Abstract][Full Text] [Related]
8. Infectious prions and proteinopathies.
Barron RM
Prion; 2017 Jan; 11(1):40-47. PubMed ID: 28281925
[TBL] [Abstract][Full Text] [Related]
9. Treatment with a non-toxic, self-replicating anti-prion delays or prevents prion disease in vivo.
Diaz-Espinoza R; Morales R; Concha-Marambio L; Moreno-Gonzalez I; Moda F; Soto C
Mol Psychiatry; 2018 Mar; 23(3):777-788. PubMed ID: 28630454
[TBL] [Abstract][Full Text] [Related]
10. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
11. Transmission and Replication of Prions.
Marín-Moreno A; Fernández-Borges N; Espinosa JC; Andréoletti O; Torres JM
Prog Mol Biol Transl Sci; 2017; 150():181-201. PubMed ID: 28838661
[TBL] [Abstract][Full Text] [Related]
12. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
13. Prions and their partners in crime.
Caughey B; Baron GS
Nature; 2006 Oct; 443(7113):803-10. PubMed ID: 17051207
[TBL] [Abstract][Full Text] [Related]
14. The Prion Concept and Synthetic Prions.
Legname G; Moda F
Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659
[TBL] [Abstract][Full Text] [Related]
15.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
16. Thermodynamic stabilization of the folded domain of prion protein inhibits prion infection in vivo.
Kong Q; Mills JL; Kundu B; Li X; Qing L; Surewicz K; Cali I; Huang S; Zheng M; Swietnicki W; Sönnichsen FD; Gambetti P; Surewicz WK
Cell Rep; 2013 Jul; 4(2):248-54. PubMed ID: 23871665
[TBL] [Abstract][Full Text] [Related]
17. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
Prion; 2015; 9(5):394-403. PubMed ID: 26555211
[TBL] [Abstract][Full Text] [Related]
18. Scrapie-associated PrP accumulation and its inhibition: revisiting the amyloid-glycosaminoglycan connection.
Caughey B; Race RE
Ann N Y Acad Sci; 1994 Jun; 724():290-5. PubMed ID: 8030949
[TBL] [Abstract][Full Text] [Related]
19. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
Saá P; Cervenakova L
Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
[TBL] [Abstract][Full Text] [Related]
20. The pathogenic mechanisms of prion diseases.
Unterberger U; Voigtländer T
CNS Neurol Disord Drug Targets; 2007 Dec; 6(6):424-55. PubMed ID: 18220781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
